Semaglutide is a GLP-1 receptor agonist that mimics a natural hormone controlling hunger and blood sugar, helping patients lose an average of 15% of body weight over 68 weeks in clinical trials
There is currently no official indication or established evidence base for using GLP-1 medications specifically to treat vasomotor symptoms associated with menopause, and they should not be used off-label for this purpose
, Wu, X
It is utilized in analytical studies regarding peptide-protein interactions, cellular structure analysis, and biochemical pathways in in vitro laboratory models
Glutathione (GSH) as distributed by Peptides Lab UK is not intended for, and must not be used for, human consumption, medical treatment, self-administration, veterinary applications, or any use outside of a controlled laboratory environment
Drink 20-30 minutes before the physical activity